Stay updated on U3-1402 in NSCLC Clinical Trial
Sign up to get notified when there's something new on the U3-1402 in NSCLC Clinical Trial page.

Latest updates to the U3-1402 in NSCLC Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedAdded a Locations section listing trial sites by state (California, Georgia, Massachusetts, Michigan, New York, Ohio, Pennsylvania, Tennessee, Texas, Washington). Updated page revision to v3.3.3 and removed the previous state-specific location blocks and the HHS Vulnerability Disclosure link.SummaryDifference0.6%

- Check23 days agoNo Change Detected
- Check44 days agoChange DetectedAdded a note that publications are automatically filled from PubMed and may not be about the study, and updated the page revision to v3.3.2; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check52 days agoChange Detected- The government funding status notice about potential delays and updates has been removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check59 days agoChange DetectedUpdated the study location entry from 'Tainan City, Taiwan, 00704' to 'Tainan, Taiwan, 00704'.SummaryDifference0.0%

- Check66 days agoChange DetectedMinor UI/layout adjustments observed in the screenshots; no core content, data, or status information appears to have changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check95 days agoChange DetectedAdded a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.SummaryDifference1%

Stay in the know with updates to U3-1402 in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the U3-1402 in NSCLC Clinical Trial page.